These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 526813)

  • 21. Smoking and elevated blood pressure are the most important risk factors for subarachnoid hemorrhage in the Asia-Pacific region: an overview of 26 cohorts involving 306,620 participants.
    Feigin V; Parag V; Lawes CM; Rodgers A; Suh I; Woodward M; Jamrozik K; Ueshima H;
    Stroke; 2005 Jul; 36(7):1360-5. PubMed ID: 15933249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral contraceptives and stroke.
    Longstreth WT; Swanson PD
    Stroke; 1984; 15(4):747-50. PubMed ID: 6380003
    [No Abstract]   [Full Text] [Related]  

  • 23. Risk factors for subarachnoid hemorrhage: a systematic review.
    Teunissen LL; Rinkel GJ; Algra A; van Gijn J
    Stroke; 1996 Mar; 27(3):544-9. PubMed ID: 8610327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertension, not pill use, found major factor in increased risk of subarachnoid hemorrhage.
    Fam Plann Perspect; 1980; 12(1):53. PubMed ID: 7364026
    [No Abstract]   [Full Text] [Related]  

  • 25. Mortality among oral-contraceptive users. Royal College of General Practitioners' Oral Contraception Study.
    Beral V
    Lancet; 1977 Oct; 2(8041):727-31. PubMed ID: 71539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thromboenbolism, oral contraceptives, and cigarettes.
    Masi AT
    Ann Intern Med; 1970 Sep; 73(3):486-7. PubMed ID: 5456000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women.
    Heinemann LA; Lewis MA; Thorogood M; Spitzer WO; Guggenmoos-Holzmann I; Bruppacher R
    BMJ; 1997 Dec; 315(7121):1502-4. PubMed ID: 9420491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Oral contraception and circulatory risks].
    Wingrave SJ
    Contracept Fertil Sex (Paris); 1984 Oct; 12(10):1111-6. PubMed ID: 12266560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Oral contraceptives: cardiovascular complications and additional risk factors (author's transl)].
    Herzog C
    Schweiz Rundsch Med Prax; 1979 Oct; 68(41):1321-9. PubMed ID: 394143
    [No Abstract]   [Full Text] [Related]  

  • 30. Smoking and subarachnoid haemorrhage.
    Taha A; Ball KP; Illingworth RD
    J R Soc Med; 1982 May; 75(5):332-5. PubMed ID: 7077616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modifiable lifestyle behaviours account for most cases of subarachnoid haemorrhage: a population-based case-control study in Australasia.
    Shiue I; Arima H; Hankey GJ; Anderson CS;
    J Neurol Sci; 2012 Feb; 313(1-2):92-4. PubMed ID: 21996272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral contraceptives and subarachnoid haemorrhage.
    Finn R; Hill CA
    Lancet; 1978 Sep; 2(8089):582. PubMed ID: 79955
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral contraceptives and stroke: findings in a large prospective study.
    Vessey MP; Lawless M; Yeates D
    Br Med J (Clin Res Ed); 1984 Sep; 289(6444):530-1. PubMed ID: 6432175
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral contraceptives and myocardial infarction: results of the MICA case-control study.
    Dunn N; Thorogood M; Faragher B; de Caestecker L; MacDonald TM; McCollum C; Thomas S; Mann R
    BMJ; 1999 Jun; 318(7198):1579-83. PubMed ID: 10364115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oral contraceptives and diseases of the circulatory system].
    Mroczek-Czernecka D
    Przegl Lek; 1990; 47(11):782-3. PubMed ID: 2098848
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevalence of secondary hypertension in a population sample of Swedish women.
    Sigurdsson JA; Bengtsson C; Tibblin E; Wojciechowski J
    Eur Heart J; 1983 Jun; 4(6):424-33. PubMed ID: 6617689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulatory disease in association with oral contraceptive use.
    Kay C
    Lancet; 1979 Sep; 2(8141):521. PubMed ID: 90231
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study.
    Croft P; Hannaford PC
    BMJ; 1989 Jan; 298(6667):165-8. PubMed ID: 2493841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral venous thrombosis and subarachnoid haemorrhage in users of oral contraceptives.
    Chilvers E; Rudge P
    Br Med J (Clin Res Ed); 1986 Feb; 292(6519):524. PubMed ID: 3081154
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular sequelae of toxaemia of pregnancy.
    Hannaford P; Ferry S; Hirsch S
    Heart; 1997 Feb; 77(2):154-8. PubMed ID: 9068399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.